Monovalent antibody design and mechanism of action of onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agent.
Proceedings Of The National Academy Of Sciences Of The United States Of America
Merchant, Mark M; Ma, Xiaolei X; Maun, Henry R HR; Zheng, Zhong Z; Peng, Jing J; Romero, Mally M; Huang, Arthur A; Yang, Nai-ying NY; Nishimura, Merry M; Greve, Joan J; Santell, Lydia L; Zhang, Yu-Wen YW; Su, Yanli Y; Kaufman, Dafna W DW; Billeci, Karen L KL; Mai, Elaine E; Moffat, Barbara B; Lim, Amy A; Duenas, Eileen T ET; Phillips, Heidi S HS; Xiang, Hong H; Young, Judy C JC; Vande Woude, George F GF; Dennis, Mark S MS; Reilly, Dorothea E DE; Schwall, Ralph H RH; Starovasnik, Melissa A MA; Lazarus, Robert A RA; Yansura, Daniel G DG